You are here


Biolidics launches IPO to raise S$6.1m

Ivan Lew, executive director and CEO of Biolidics, with the company's patented technology that can separate cancer cells from blood to test for the presence of cancer.


MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.

The shares will be placed out to retail and...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to